Hematopoiesis News Volume 15.00 | Jan 9 2024

    0
    11








    2024-01-09 | HN 15.01


    Hematopoiesis News by STEMCELL Technologies
    Vol. 15.00 – 9 January, 2024
    TOP STORY

    A Time- and Single-Cell-Resolved Model of Murine Bone Marrow Hematopoiesis

    Scientists combined persistent labeling with time-series single-cell RNA sequencing to build a real-time, quantitative model of in vivo tissue dynamics for murine bone marrow hematopoiesis.
    [Cell Stem Cell]

    Full ArticleGraphical Abstract
    Human whole peripheral blood for your large-scale studies. Click to learn more.
    PUBLICATIONSRanked by the impact factor of the journal

    TMIGD2 Is an Orchestrator and Therapeutic Target on Human Acute Myeloid Leukemia Stem Cells

    Researchers showed that transmembrane and immunoglobulin domain containing 2 (TMIGD2), a recently discovered co-stimulatory immune receptor, was aberrantly expressed by human AML cells, and can be used to identify and enrich functional leukemia stem cells.
    [Nature Communications]

    Full Article

    Nlrc3 Signaling Is Indispensable for Hematopoietic Stem Cell Emergence via Notch Signaling in Vertebrates

    Investigators found that Nlrc3, a nucleotide-binding domain leucine-rich repeat containing family gene, was highly expressed in hematopoietic differentiation stages in vivo and vitro and was required in hematopoiesis in zebrafish.
    [Nature Communications]

    Full Article

    FLT3 Tyrosine Kinase Inhibition Modulates PRC2 and Promotes Differentiation in Acute Myeloid Leukemia

    The authors demonstrated that FLT3 inhibitors increased myeloid maturation with reduced stem/progenitor cell populations in murine fms-like tyrosine kinase 3 (FLT3-ITD) AML.
    [Leukemia]

    Full Article

    CBFA2T3::GLIS2 Pediatric Acute Megakaryoblastic Leukemia Is Sensitive to BCL-XL Inhibition by Navitoclax and DT2216

    Investigators established CD34+ cord blood–derived CBFA2T3::GLIS2models that sustained serial transplantation and recapitulated human leukemia regarding immunophenotype, leukemia-initiating cell frequencies, comutational landscape.
    [Blood Advances]

    Full ArticleGraphical Abstract

    Distinct Roles of Hematopoietic Cytokines in the Regulation of Leukemia Stem Cells in Murine MLL-AF9 Leukemia

    Using an MLL-AF9-induced murine acute myeloid leukemia model, researchers studied the role of hematopoietic cytokines in the survival of lymphoid-primed multipotent progenitor- and granulocyte-monocyte progenitor-like leukemia stem cells.
    [Stem Cell Reports]

    Full ArticleGraphical Abstract

    MarrowCellDLD: A Microfluidic Method for Label-Free Retrieval of Fragile Bone Marrow-Derived Cells

    MarrowCellDLD enabled the isolation of large, fragile bona marrow-derived cells based on intrinsic size properties while preserving their viability and functionality.
    [Scientific Reports]

    Full Article

    Bone Marrow Graft Versus Peripheral Blood Graft in Haploidentical Hematopoietic Stem Cells Transplantation: A Retrospective Analysis in 1344 Patients of SFGM-TC Registry

    A total of 1344 adult patients received an unmanipulated haploidentical transplant at 37 centers from 2012 to 2019 for hematologic malignancy. Investigators compared the outcomes of patients according to the type of graft, using a propensity score analysis.
    [Journal Of Hematology & Oncology]

    Full Article

    Matched Unrelated Donor Transplantation Versus Haploidentical Transplantation with Post-Transplant Cyclophosphamide in Children with Acute Myeloid Leukemia: A PDWP-EBMT Study

    Researchers compared outcomes of patients under 18 years with AML in first and second complete remission undergoing a hematopoietic stem cell transplantation (HCT) either with a MUD with anti-thymocyte globuline or a haplo HCT with PT-CY after a myeloablative conditioning regimen between 2011 and 2021.
    [Haematologica]

    Abstract
    Discover new celli Isolation technologies
    REVIEWS

    Exploring Hematopoiesis in Zebrafish Using Forward Genetic Screening

    Scientists provide an overview of the zebrafish forward screening approach for hematopoietic gene discovery and highlight the key genes and pathways identified using this method.
    [Experimental & Molecular Medicine]

    Full Article

    Ex Vivo Hematopoietic Stem Cell Expansion Technologies: Recent Progress, Applications, and Open Questions

    The authors summarize recent progress in ex vivo HSC expansion technologies and their applications to biological and clinical problems and discusses current questions in the field.
    [Experimental Hematology]

    Abstract
    INDUSTRY AND POLICY NEWS

    Clinical Trial Begins for Novel Natural Killer Cell Therapy

    Cincinnati Children’s is one of a few centers in the nation to test a novel therapy that uses cytokine-induced memory-like natural killer cells from haploidentical donors to treat AML. This study is open to patients ages 12- 45 years with relapsed or refractory AML who haven’t undergone bone marrow transplantation.
    [Cincinnati Children’s]

    Press Release

    Topline Results from MYLOX-1 Trial Demonstrate Reduction in Fibrosis of the Bone Marrow in Patients with Myelofibrosis

    Galecto, Inc. announced positive topline results from a Phase IIa trial of GB2064 for the treatment of myelofibrosis. The MYLOX-1 trial dosed a total of 18 myelofibrosis patients.
    [Galecto, Inc.]

    Press Release
    FEATURED EVENT

    London Biotechnology Show 2024

    February 27 – 28, 2024
    London, England, United Kingdom

    > See All Events

    JOB OPPORTUNITIES

    Research Associate – Translational Pediatric Oncology

    City of Hope – Duarte, California, United States

    Research Assistant – Hematopoietic Biology & Malignancy

    MD Anderson Cancer Center – Houston, Texas, United States

    PhD Positions – Tissue Regeneration and Cancer Immunotherapy

    Albert-Ludwigs-University Freiburg – Freiburg im Breisgau, Germany

    Animal Technician – Experimental Therapeutics

    BC Cancer – Vancouver, British Columbia, Canada

    PhD Position – Aging of Human Hematopoietic Stem Cells

    Karolinska Institutet – Flemingsberg, Sweden

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2